We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$1.94M
Cap. Flow
-$12M
Cap. Flow %
-5.58%
Top 10 Hldgs %
39.29%
Holding
99
New
24
Increased
11
Reduced
21
Closed
34

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.98M
2
ABBV icon
AbbVie
ABBV
+$4.46M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$4.25M
4
HCA icon
HCA Healthcare
HCA
+$4.22M
5
THC icon
Tenet Healthcare
THC
+$3.84M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$8.04M
2
CI icon
Cigna
CI
+$6.22M
3
MRK icon
Merck
MRK
+$3.29M
4
PFE icon
Pfizer
PFE
+$3.21M
5
INCY icon
Incyte
INCY
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 67.42%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
76
CALL
Johnson & Johnson
JNJ
$626B
– –
-50,000
Closed -$4.91M
LH icon
77
CALL
Labcorp
LH
$26.1B
– –
-29,100
Closed -$2.46M
LLY icon
78
CALL
Eli Lilly
LLY
$1.08T
– –
-65,000
Closed -$3.83M
LSTA icon
79
Lisata Therapeutics
LSTA
$10.9M
– –
-1,333
Closed -$1.41M
MBOT icon
80
Microbot Medical
MBOT
$113M
– –
-154
Closed -$335K
MDT icon
81
CALL
Medtronic
MDT
$116B
– –
-75,000
Closed -$4.62M
MRK icon
82
CALL
Merck
MRK
$322B
– –
-60,994
Closed -$3.3M
NVS icon
83
CALL
Novartis
NVS
$294B
– –
-16,740
Closed -$1.27M
OPCH icon
84
CALL
Option Care Health
OPCH
$3.61B
– –
-25,000
Closed -$698K
PFE icon
85
Pfizer
PFE
$152B
– –
-105,400
Closed -$3.21M
PRTA icon
86
Prothena Corp
PRTA
$473M
– –
-25,000
Closed -$958K
TEVA icon
87
CALL
Teva Pharmaceuticals
TEVA
$42.5B
– –
-50,000
Closed -$2.64M
ZBH icon
88
Zimmer Biomet
ZBH
$18.5B
– –
-87,550
Closed -$8.04M
EPZM
89
CALL
DELISTED
Epizyme, Inc
EPZM
– –
-30,000
Closed -$683K
MNTA
90
PUT
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-32,500
Closed -$378K
HZNP
91
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-15,000
Closed -$227K
ECYT
92
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-75,000
Closed -$1.79M
FMI
93
PUT
DELISTED
Foundation Medicine, Inc.
FMI
– –
-10,000
Closed -$324K
IPXL
94
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-100,000
Closed -$2.64M
RXDX
95
DELISTED
Ignyta, Inc.
RXDX
– –
-63,833
Closed -$530K
CTRX
96
PUT
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
– –
-25,000
Closed -$1.12M
ZGNX
97
DELISTED
Zogenix, Inc.
ZGNX
– –
-18,750
Closed -$427K
PCYC
98
PUT
DELISTED
PHARMACYCLICS INC
PCYC
– –
-10,000
Closed -$1M
ARTC
99
CALL
DELISTED
ARTHROCARE CORP
ARTC
– –
-10,000
Closed -$482K
1 2 3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2014 Portfolio in Review

As of Q2 2014, Iguana Healthcare Management held 99 positions worth $214M, down 0.89% from $216M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Iguana Healthcare Management withdrew a net $12M in Q2 2014, closing 34 positions and reducing 21 holdings. Its most notable exit was Zimmer Biomet, an estimated $8.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Industrials.

Against the trend, Iguana Healthcare Management opened a new position in Celgene Corp worth $9.02M.

  • Iguana Healthcare Management's largest Q2 2014 buy was Celgene Corp: 105,000 shares worth $9.02M.
  • Iguana Healthcare Management added most to Medtronic in Q2 2014, an estimated $2.58M increase.
  • Iguana Healthcare Management's biggest Q2 2014 reduction was Cigna, cutting an estimated $6.22M.
  • Iguana Healthcare Management fully exited Zimmer Biomet in Q2 2014, selling an estimated $8.04M.
  • Iguana Healthcare Management's ten largest holdings make up 39% of its $214M portfolio in Q2 2014.
  • Iguana Healthcare Management opened 24 new positions and closed 34 in Q2 2014.
  • Iguana Healthcare Management's portfolio value fell 0.89% quarter-over-quarter to $214M.

Based on Iguana Healthcare Management's 13F filing for Q2 2014, filed 14 Aug 2014.